English
This article is from Avicenna Journal of Medicine , volume 3 . Abstract Backgound:: Treatment of serious life-threatening multi-drug-resistant organisms poses a serious problem due to the limited therapeutic options. Tigecycline has been recently marketed as a broad-spectrum antibiotic with activity against both gram-positive and gram-negative bacteria. Even though many studies have demonstrated the activity of tigecycline against ESBL-producing Enterobacteriaceae, its activity is not well-defined against micro-organisms producing metallo-β-lactamases (MBLs), as there are only a few reports and the number of isolates tested is limited. Aims:: The aim of the present study was to evaluate the activity of tigecycline against MBL-producing bacterial isolates. Materials and Methods:: The isolates were tested for MBL production by (i) combined-disk test, (ii) double disc synergy test (DDST), (iii) susceptibility to aztreonam (30 μg) disk. Minimum inhibitory concentration to tigecycline was determined according to agar dilution method as per Clinical Laboratory Standards Institute (CLSI) guidelines. Disc diffusion susceptibility testing was also performed for all these isolates using tige
Sign in with your free account to read, download EPUBs or listen.
Ebook · Tigecycline activity against metallo-?-lactamase-producing bacteria. · Kumar, Simit, Bandyopadhyay, Maitreyi, Mondal, Soma, Pal, Nupur, Ghosh, Tapashi, Bandyopadhyay, Manas, Banerjee, Parthajit · Internet Archive